Martin Austin

Licensing, Selling and Finance in the Pharmaceutical and Healthcare Industries (eBook, ePUB)

The Commercialization of Intellectual Property

• Format: ePub

Produktbeschreibung

Licensing, Selling and Finance in the Pharmaceutical and Healthcare Industries is an assessment of the turbulent state of pharmaceutical and biotechnology markets as we enter the second decade of the 21st century. At the same time, the book offers a cautionary evaluation of the future financing of innovation in terms of what's gone wrong and how to succeed in the future. Martin Austin explores the challenge that the pharmaceutical (and related) industries face in terms of balancing short term, cost containment and expenditure control in areas such as internal research and development; whilst embracing in-licensing and the acquisition of innovative therapies to counteract their impending portfolio weaknesses in the mid to longer term.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Taylor & Francis
• Seitenzahl: 192
• Erscheinungstermin: 6. Mai 2016
• Englisch
• ISBN-13: 9781317105305
• Artikelnr.: 45092919

Autorenporträt

Martin Austin is Managing Director of TransformRx GmbH, formed in 2005 to provide business advice to clients on investment and business development. He is also a Partner in MarraM Advisors, specialising in Industrial Biotechnology, a Board member of RSA AG and Chairman of Zestagen SA a biotech start-up in Lausanne. He was previously a Principal in the Paul Capital Partners Royalty Funds, a USA-based specialist in Secondary Private Equity and Alternative Asset Investments and previously Head of Business Development for the Pharmaceuticals Division at F. Hoffmann-La Roche. After a broad ranging career in the Pharmaceutical industry, progressing through Sales and Marketing roles with GD Searle in the early 1980's, he went on to become Business Development Manager with Lorex Pharmaceuticals before leaving to become a founding Director of Machine Intelligence Technologies. He was then appointed Managing Director of MHIG Ltd, an international joint venture in Market Research, prior to joining Roche.

Inhaltsangabe

Introduction
Part I The Challenge
Chapter 1 Novel Market Challenges
Chapter 2 What is Intellectual Property?
Part II Models and Solutions
Chapter 3 Market Opportunities
Chapter 4 Modeling and Forecasting
Chapter 5 Valuation
Chapter 6 Development Costs of Intellectual Property
Chapter 7 Commercial Strategy for Intellectual Property
Chapter 8 Marketing Intellectual Property in Healthcare
Chapter 9 Licensing, Selling and Finance
Chapter 10 Contract Execution
Chapter 11 Agreements